XML 45 R31.htm IDEA: XBRL DOCUMENT v3.21.2
SHARE-BASED PAYMENTS (Tables)
9 Months Ended
Sep. 30, 2021
Share-based Payment Arrangement [Abstract]  
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions
The fair value of the options granted under the Compensation Plan for the nine months ended September 30, 2021 was estimated at the date of grant, using the Black-Scholes Option Valuation Model, with the following weighted average assumptions:
Risk-free interest rate0.44 %
Expected life (in years)5.0
Expected volatility61.96 %*
Expected dividend yield— %
Weighted average grant date fair value$2.06 
*Expected volatility is measured based on the Company’s historical share price volatility over a period equivalent to the expected life of the options.
Schedule of Share-based Compensation, Stock Options, Activity The summary of the Company’s stock options at September 30, 2021 and December 31, 2020, and the changes for the fiscal periods ending on those dates, is presented below:
 Range of Exercise PricesNumber of SharesWeighted Average
Exercise Price
Weighted Average Remaining Contractual Life (Years)Intrinsic Value
Outstanding, December 31, 2019
$1.70 - $15.61
1,487,433 $3.43 
 Granted(1)
1.76 - 3.06
711,414 1.77 
 Exercised
 1.70 - 2.92
(302,707)1.97 
 Forfeited
1.70 - 5.18
(188,541)3.26 
 Expired
4.12 - 5.22
(98,512)4.40 
Outstanding, December 31, 2020
$1.70 - $15.61
1,609,087 $2.91 
 Granted
3.89 - 7.14
169,210 3.99 
 Exercised
1.70 - 7.42
(615,591)2.65 
 Forfeited
1.76 - 5.91
(8,049)3.16 
 Expired
1.70 - 15.61
(51,653)8.14 
Outstanding, September 30, 2021
$1.70 - $7.42
1,103,004 $2.98 2.54
Exercisable, September 30, 2021
$1.70 - $7.42
888,627 $3.06 2.25$3,540 

(1) Includes 0.71 million options granted in the nine months ended September 30, 2020.
A summary of the status and activity of non-vested stock options for the nine months ended September 30, 2021 is as follows:
 Number of SharesWeighted Average Grant Date Fair Value
Non-vested December 31, 2020403,990 $0.94 
 Granted169,210 2.06 
 Vested(350,774)1.23 
 Forfeited(8,049)1.60 
Non-vested September 30, 2021214,377 $1.34 
Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity
A summary of the status and activity of non-vested RSUs for the nine months ended September 30, 2021 is as follows:
 Number of SharesWeighted Average Grant Date Fair Value
Non-vested December 31, 20201,094,056 $1.98 
 Granted441,241 3.89 
 Vested(635,233)1.94 
 Forfeited— — 
Non-vested September 30, 2021900,064 $2.94 
The summary of the Company’s SARs at September 30, 2021 and December 31, 2020, and the changes for the fiscal periods ending on those dates, is presented below:
 Number of SharesWeighted Average
Exercise Price
Balance, December 31, 20192,165,509 $2.92 
 Granted— — 
 Exercised— — 
 Forfeited(444,886)2.92 
 Expired— — 
Balance, December 31, 20201,720,623 $2.92 
 Granted— — 
 Exercised(17,793)2.92 
 Forfeited— — 
 Expired— — 
Balance, September 30, 20211,702,830 2.92 
A summary of the status and activity of non-vested SARs for the nine months ended September 30, 2021 is as follows:
 Number of SharesWeighted Average Grant Date Fair Value
Non-vested December 31, 20201,720,623 $1.25 
 Granted— — 
 Vested(573,537)1.25 
 Forfeited— — 
Non-vested September 30, 20211,147,086 $1.25 
Disclosure of Share-based Compensation Arrangements by Share-based Payment Award
The components of share-based compensation are as follows:
Three months ended
September 30,
Nine months ended
September 30,
2021202020212020
Recognized expense
Stock options$42 $134 $281 $508 
RSU awards409 306 1,162 986 
SARs62 230 260 876 
Total recognized expense$513 $670 $1,703 $2,370